Nurtec ODT 75 MG tablet 8S
Ended Awarded Last action
- Contract number
- SPE2DR26FV7N5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,491
Award facts
- Contract value 100% obligated
- $11,491.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $11,491.08 by the Defense Logistics Agency on January 9, 2026, for the supply of NURTEC ODT 75 mg tablets (8-count). This firm fixed-price, non-set-aside contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 12, 2026. The delivery order represents a task order executed under Cencora's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
NURTEC ODT is a migraine treatment medication indicated for acute treatment of migraine headaches, making this a routine pharmaceutical procurement supporting the Defense Health Agency and other federal military healthcare systems. AmerSourceBergen's role as a critical pharmaceutical distributor under the DLA prime vendor contract demonstrates the company's ongoing capability to fulfill federal medical supply requirements across multiple therapeutic domains. The non-set-aside competitive award reflects the company's established position as a major supplier of both brand-name and generic medications, vaccines, and specialized medical supplies to the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26FV7N5?
SPE2DR26FV7N5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FV7N5 worth?
The government has obligated $11,491 on SPE2DR26FV7N5.
Is contract SPE2DR26FV7N5 an order under another contract?
Yes. SPE2DR26FV7N5 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7N5 competed?
The extent of competition for SPE2DR26FV7N5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award